REMEDY, Research Ethics in Medicine Study Group works on ethics and policy of biomedical research. Our team has expertise in philosophy, biology, biomedical engineering, mathematics, biostatistics and public health.


We adapt advanced methods of the Evidence Based Medicine and meta-research to answer questions in bioethics. Our main area of interest is research in oncology, including paediatric research.


Our new commentary: Waligora M, Strzebonska K, Wasylewski MT, Neither the Harm Principle nor the Best Interest Standard Should Be Applied to Pediatric Research, American Journal of Bioethics, 2018 Aug.

Connecting Research and Democracy. Lauren Kaye about Marcin Waligora’s research at the Harvard Medical School Center for Bioethics.

Karolina Strzebońska presented a poster on dose expansion cohorts in pediatric phase I cancer research at the Evidence Live conference in Oxford.

Marcin Waligóra discussed our recent study at the Johns Hopkins Berman Institute of Bioethics, Baltimore, USA. See YouTube Video.

STAT about our recent study: New study raises questions about early-stage cancer therapies for children.

Read a commentary by Jonathan Kimmelman on our findings: Part 1 and Part 2.